Edwards Financial Statements From 2010 to 2024

EW Stock  USD 71.27  0.79  1.12%   
Edwards Lifesciences financial statements provide useful quarterly and yearly information to potential Edwards Lifesciences Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Edwards Lifesciences financial statements helps investors assess Edwards Lifesciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Edwards Lifesciences' valuation are summarized below:
Gross Profit
4.3 B
Profit Margin
0.6586
Market Capitalization
41.6 B
Enterprise Value Revenue
5.9905
Revenue
6.3 B
There are over one hundred nineteen available fundamental signals for Edwards Lifesciences Corp, which can be analyzed over time and compared to other ratios. All traders should should verify Edwards Lifesciences' prevailing fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to climb to about 45.9 B in 2024. Enterprise Value is likely to climb to about 45.4 B in 2024

Edwards Lifesciences Total Revenue

6.31 Billion

Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.7 M, Interest Expense of 10.6 M or Selling General Administrative of 1.8 B, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 4.82. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
  
Check out the analysis of Edwards Lifesciences Correlation against competitors.

Edwards Lifesciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets9.8 B9.4 B5.4 B
Slightly volatile
Other Current Liabilities863 M821.9 M440.7 M
Slightly volatile
Total Current Liabilities1.3 B1.2 B747 M
Slightly volatile
Total Stockholder EquityB6.7 B3.5 B
Slightly volatile
Property Plant And Equipment Net1.9 B1.8 B943.4 M
Slightly volatile
Retained Earnings9.4 BBB
Slightly volatile
Non Current Assets Total5.6 B5.3 BB
Slightly volatile
Non Currrent Assets Other486.9 M463.7 M145.4 M
Slightly volatile
Cash And Short Term Investments1.7 B1.6 B1.1 B
Slightly volatile
Net Receivables878.7 M836.9 M501.1 M
Slightly volatile
Good Will688.6 M1.3 B829.5 M
Slightly volatile
Common Stock Shares Outstanding550.8 M609.4 M649.6 M
Slightly volatile
Liabilities And Stockholders Equity9.8 B9.4 B5.4 B
Slightly volatile
Non Current Liabilities Total800.7 M1.4 B1.1 B
Slightly volatile
Inventory1.2 B1.2 B577 M
Slightly volatile
Other Current Assets405.4 M386.1 M176.8 M
Slightly volatile
Total Liabilities1.4 B2.6 B1.8 B
Slightly volatile
Property Plant And Equipment Gross2.8 B2.7 B1.1 B
Slightly volatile
Total Current Assets4.2 BB2.4 B
Slightly volatile
Short and Long Term Debt Total486.4 M694.9 M596.5 M
Slightly volatile
Other Liabilities963.1 M917.2 M603.8 M
Slightly volatile
Accounts Payable139.5 M201.4 M130.7 M
Slightly volatile
Cash1.2 B1.1 B740.3 M
Slightly volatile
Other Assets945.6 M900.6 M400.6 M
Slightly volatile
Long Term Debt425.6 M597 M516.9 M
Slightly volatile
Common Stock Total Equity780.4 M743.2 M342.2 M
Slightly volatile
Intangible Assets449.8 M428.4 M273.5 M
Slightly volatile
Common Stock683 M650.5 M329.6 M
Slightly volatile
Property Plant Equipment2.1 BB948.1 M
Slightly volatile
Short Term Investments382.6 M500.5 M396 M
Pretty Stable
Net Tangible Assets5.3 BB2.5 B
Slightly volatile
Capital Surpluse1.2 B2.3 B1.2 B
Slightly volatile
Long Term Investments582.2 M583.9 M532.8 M
Slightly volatile
Non Current Liabilities Other454.3 M264.3 M415.8 M
Slightly volatile
Deferred Long Term Asset Charges246.1 M234.4 M157.4 M
Slightly volatile
Long Term Debt Total583.3 M685.7 M518.9 M
Slightly volatile
Short and Long Term Debt719.2 M687.7 M627 M
Pretty Stable
Cash And EquivalentsB884.4 M929.1 M
Very volatile
Net Invested Capital5.9 B7.2 B4.8 B
Slightly volatile
Net Working Capital2.2 B2.8 B1.6 B
Slightly volatile
Capital Stock551.6 M650.5 M352.1 M
Slightly volatile
Capital Lease Obligations103.8 M97.9 M89 M
Slightly volatile

Edwards Lifesciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization89.7 M144.9 M101.1 M
Slightly volatile
Selling General Administrative1.8 B1.8 B1.1 B
Slightly volatile
Total Revenue6.3 BB3.5 B
Slightly volatile
Gross Profit4.9 B4.6 B2.7 B
Slightly volatile
Other Operating Expenses4.5 B4.3 B2.6 B
Slightly volatile
Operating Income1.6 B1.5 B931.8 M
Slightly volatile
Research Development1.1 B1.1 B588.1 M
Slightly volatile
Cost Of Revenue697.9 M1.4 B828.6 M
Slightly volatile
Total Operating ExpensesB2.9 B1.7 B
Slightly volatile
Income Before Tax1.7 B1.6 B962.2 M
Slightly volatile
Net Income1.5 B1.4 B799.6 M
Slightly volatile
Income Tax Expense113.1 M198.7 M156.6 M
Pretty Stable
Net Income Applicable To Common Shares1.8 B1.8 B842.8 M
Slightly volatile
Net Income From Continuing Ops836.3 M1.4 B765.4 M
Slightly volatile
Tax Provision201.8 M207.6 M166 M
Pretty Stable
Interest Income70.6 M67.2 M21.5 M
Slightly volatile
Reconciled Depreciation121.6 M143.6 M97.9 M
Slightly volatile
Selling And Marketing Expenses953.3 K1.2 M456.9 K
Slightly volatile

Edwards Lifesciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow444.3 M629.5 M620.9 M
Slightly volatile
Depreciation81.8 M144.9 M88.7 M
Slightly volatile
Capital Expenditures146.6 M266.3 M193.2 M
Slightly volatile
Total Cash From Operating Activities590.9 M895.8 M814.1 M
Slightly volatile
Net Income1.5 B1.4 B796.6 M
Slightly volatile
End Period Cash Flow1.2 B1.1 B742.5 M
Slightly volatile
Stock Based Compensation146.4 M139.4 M79.3 M
Slightly volatile
Begin Period Cash Flow499 M772.6 M645.7 M
Slightly volatile
Cash Flows Other Operating1.8 B1.7 B859.4 M
Slightly volatile
Issuance Of Capital Stock169.1 M184.6 M154.6 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.367.7047.3373
Slightly volatile
PTB Ratio4.826.95657.6669
Slightly volatile
Days Sales Outstanding60.1950.870754.3166
Slightly volatile
Book Value Per Share11.6311.07535.6497
Slightly volatile
Free Cash Flow Yield0.01290.01360.034
Slightly volatile
Operating Cash Flow Per Share1.551.47651.3282
Slightly volatile
Average Payables67.7 M67.1 M60 M
Slightly volatile
Stock Based Compensation To Revenue0.02370.02320.0213
Very volatile
Capex To Depreciation1.31.83782.1063
Slightly volatile
PB Ratio4.826.95657.6669
Slightly volatile
EV To Sales4.397.62927.3115
Slightly volatile
Free Cash Flow Per Share1.091.03761.0074
Slightly volatile
ROIC0.120.18470.1739
Slightly volatile
Inventory Turnover1.121.18111.6988
Slightly volatile
Net Income Per Share2.432.31151.2761
Slightly volatile
Days Of Inventory On Hand324309226
Slightly volatile
Payables Turnover4.786.8516.898
Pretty Stable
Sales General And Administrative To Revenue0.360.30370.3188
Slightly volatile
Research And Ddevelopement To Revenue0.10.17850.1515
Slightly volatile
Capex To Revenue0.04430.04430.0568
Very volatile
Cash Per Share2.852.71061.812
Slightly volatile
POCF Ratio54.2251.64232.7218
Slightly volatile
Interest Coverage63.9787.164889.1205
Very volatile
Capex To Operating Cash Flow0.310.29730.2513
Pretty Stable
PFCF Ratio77.1673.488344.9109
Slightly volatile
Days Payables Outstanding94.7553.276661.5571
Very volatile
Income Quality0.610.64011.2115
Slightly volatile
ROE0.110.21090.2126
Very volatile
EV To Operating Cash Flow53.751.140632.5596
Slightly volatile
PE Ratio31.3432.986935.5028
Slightly volatile
Return On Tangible Assets0.0960.18260.1734
Very volatile
EV To Free Cash Flow76.4172.774944.6743
Slightly volatile
Earnings Yield0.01690.03030.0332
Slightly volatile
Intangibles To Total Assets0.320.17960.2337
Pretty Stable
Current Ratio2.333.3763.4179
Slightly volatile
Tangible Book Value Per Share8.728.30313.8884
Slightly volatile
Receivables Turnover5.467.17516.7874
Slightly volatile
Graham Number25.0723.876112.6476
Slightly volatile
Shareholders Equity Per Share11.5110.96095.6341
Slightly volatile
Debt To Equity0.08880.09350.2424
Slightly volatile
Capex Per Share0.460.43890.3207
Slightly volatile
Revenue Per Share10.399.89755.628
Slightly volatile
Interest Debt Per Share0.541.05410.9029
Slightly volatile
Debt To Assets0.06310.06640.1349
Slightly volatile
Enterprise Value Over EBITDA16.9125.917525.4213
Slightly volatile
Short Term Coverage Ratios22.0535.975921.2631
Slightly volatile
Price Earnings Ratio31.3432.986935.5028
Slightly volatile
Operating Cycle188360268
Slightly volatile
Price Book Value Ratio4.826.95657.6669
Slightly volatile
Days Of Payables Outstanding94.7553.276661.5571
Very volatile
Price To Operating Cash Flows Ratio54.2251.64232.7218
Slightly volatile
Price To Free Cash Flows Ratio77.1673.488344.9109
Slightly volatile
Pretax Profit Margin0.140.26610.2524
Pretty Stable
Ebt Per Ebit0.621.04171.0551
Pretty Stable
Operating Profit Margin0.160.25550.2405
Slightly volatile
Effective Tax Rate0.220.12430.1939
Slightly volatile
Company Equity Multiplier1.821.4081.5808
Pretty Stable
Long Term Debt To Capitalization0.07830.08240.1643
Slightly volatile
Total Debt To Capitalization0.08120.08550.177
Slightly volatile
Return On Capital Employed0.140.18780.1888
Slightly volatile
Debt Equity Ratio0.08880.09350.2424
Slightly volatile
Ebit Per Revenue0.160.25550.2405
Slightly volatile
Quick Ratio1.782.39882.6517
Slightly volatile
Dividend Paid And Capex Coverage Ratio3.153.36394.4615
Pretty Stable
Net Income Per E B T0.650.87750.7975
Pretty Stable
Cash Ratio0.680.9570.9843
Very volatile
Cash Conversion Cycle322307231
Slightly volatile
Operating Cash Flow Sales Ratio0.170.14920.2424
Very volatile
Days Of Inventory Outstanding324309226
Slightly volatile
Days Of Sales Outstanding60.1950.870754.3166
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.580.70270.7414
Pretty Stable
Cash Flow Coverage Ratios1.141.44041.4747
Slightly volatile
Price To Book Ratio4.826.95657.6669
Slightly volatile
Fixed Asset Turnover4.913.25754.3712
Slightly volatile
Capital Expenditure Coverage Ratio3.153.36394.4615
Pretty Stable
Price Cash Flow Ratio54.2251.64232.7218
Slightly volatile
Enterprise Value Multiple16.9125.917525.4213
Slightly volatile
Debt Ratio0.06310.06640.1349
Slightly volatile
Cash Flow To Debt Ratio1.141.44041.4747
Slightly volatile
Price Sales Ratio4.367.7047.3373
Slightly volatile
Return On Assets0.0780.14980.1359
Pretty Stable
Asset Turnover0.80.64130.6865
Slightly volatile
Net Profit Margin0.250.23350.2116
Slightly volatile
Gross Profit Margin0.540.77020.7168
Pretty Stable
Price Fair Value4.826.95657.6669
Slightly volatile
Return On Equity0.110.21090.2126
Very volatile

Edwards Lifesciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap45.9 B43.7 B36.7 B
Slightly volatile
Enterprise Value45.4 B43.3 B36.4 B
Slightly volatile

Edwards Fundamental Market Drivers

Forward Price Earnings29.0698
Cash And Short Term Investments1.6 B

Edwards Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue953.9 M554.1 M
Total RevenueB6.3 B
Cost Of Revenue1.4 B697.9 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.30  0.36 
Research And Ddevelopement To Revenue 0.18  0.10 
Capex To Revenue 0.04  0.04 
Revenue Per Share 9.90  10.39 
Ebit Per Revenue 0.26  0.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.